Vaxart Inc.

News & Events

Press Releases

In The Media

1. Vaxart Announces Preliminary Results of Annual Meeting of Stockholders

   GlobeNewswire JUN 13, 2025 4:52 PM EDT
   SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) ( ...
   READ ARTICLE

2. Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

   GlobeNewswire JUN 11, 2025 7:30 AM EDT
   - Second-generation norovirus constructs produce statistically significant increases in GI.1 and ...
   READ ARTICLE

3. Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

   GlobeNewswire JUN 10, 2025 4:47 PM EDT
   SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a cli...
   READ ARTICLE

4. Vaxart Announces Adjournment of Annual Meeting of Stockholders

   GlobeNewswire JUN 2, 2025 4:20 PM EDT
   Meeting adjourned to June 13, 2025 at 8:30 a.m. Pacific Time Vaxart&#x...
   READ ARTICLE

5. Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025

   GlobeNewswire MAY 29, 2025 4:05 PM EDT
   SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clin...
   READ ARTICLE

6. Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders

   GlobeNewswire MAY 29, 2025 8:00 AM EDT
   Dr. Sean Tucker, Founder and CSO of Vaxart, Urges Stockholders to Vote FOR Reverse Stock Split Pr...
   READ ARTICLE

7. Vaxart Answers Additional Frequently Asked Questions from Retail Investors

   GlobeNewswire MAY 28, 2025 8:00 AM EDT
   Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on...
   READ ARTICLE

8. Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

   GlobeNewswire MAY 27, 2025 8:00 AM EDT
   - Study will assess relative efficacy, safety, and immunogenicity of Vaxart’s oral pill CO...
   READ ARTICLE

9. Vaxart Announces Adjournment of Annual Meeting of Stockholders

   GlobeNewswire MAY 21, 2025 4:45 PM EDT
   Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart ...
   READ ARTICLE

10. Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    GlobeNewswire MAY 20, 2025 5:00 PM EDT
    SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (t...
    READ ARTICLE